organophosphonates has been researched along with Drug Abuse, Intravenous in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 15 (88.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karim, SS | 1 |
| Chiamwongpaet, S; Choopanya, K; Chuachoowong, R; Curlin, ME; Gvetadze, RJ; Hendrix, CW; Kitisin, P; Kittimunkong, S; Leethochawalit, M; Martin, M; McNicholl, JM; Mock, PA; Natrujirote, P; Paxton, LA; Sangkum, U; Suntharasamai, P; Vanichseni, S | 1 |
| Rosenberg, K | 1 |
| Yongfeng, Y; Zhiliang, H | 1 |
| Cole, SR; Hudgens, MG | 1 |
| Hoffman, IF; Latkin, CA; Miller, WC; Shoptaw, S; Strathdee, SA | 1 |
| Craig, AP; Gray, R; Jansson, J; Wilson, DP | 1 |
| Choopanya, K; Martin, M; Mock, PA; Sangkum, U; Suntharasamai, P; Vanichseni, S | 1 |
| Bender, BS | 1 |
| Chaipung, B; Chiamwongpaet, S; Choopanya, K; Curlin, ME; Gvetadze, RJ; Kittimunkong, S; Leethochawalit, M; Martin, M; McNicholl, JM; Mock, PA; Paxton, LA; Sangkum, U; Suntharasamai, P; Vanichseni, S | 1 |
| León, E; Lozano de León-Naranjo, F; Pérez-Rivera, AÁ; Sáez, P | 1 |
| Chiamwongpaet, S; Choopanya, K; Chuachoowong, R; Kittimunkong, S; Leethochawalit, M; Martin, M; McNicholl, JM; Mock, PA; Paxton, L; Sangkum, U; Suntharasamai, P; van Griensven, F; Vanichseni, S | 1 |
| Esser, S; Gölz, J; Haberl, A; Körber, A; Lazzarin, A; Mulcahy, F; Staszewski, S; Teofilo, E; Vera, J | 1 |
| Naggie, S; Sulkowski, MS | 1 |
| Cauda, R; Cingolani, A; De Luca, A; Di Giambenedetto, S; Marzocchetti, A; Pompucci, A; Scoppettuolo, G; Tumbarello, M; Vago, G | 1 |
| Cohen, J | 1 |
1 review(s) available for organophosphonates and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.
Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Coinfection; Deoxycytidine; Dideoxynucleosides; Disease Progression; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Emtricitabine; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Diseases; Male; Oligopeptides; Organophosphonates; Polyethylene Glycols; Proline; Pyrrolidinones; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Substance Abuse, Intravenous; Tenofovir; Treatment Outcome | 2012 |
3 trial(s) available for organophosphonates and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Topics: Adenine; Adult; Anti-HIV Agents; Double-Blind Method; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Substance Abuse, Intravenous; Tenofovir; Thailand; Treatment Outcome; Young Adult | 2013 |
High Mortality Among Non-HIV-Infected People Who Inject Drugs in Bangkok, Thailand, 2005-2012.
Topics: Accidents, Traffic; Adenine; Adult; Anti-HIV Agents; Cause of Death; Double-Blind Method; Drug Overdose; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Needle Sharing; Organophosphonates; Pre-Exposure Prophylaxis; Risk-Taking; Substance Abuse, Intravenous; Surveys and Questionnaires; Tenofovir; Thailand | 2015 |
Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand.
Topics: Adenine; Administration, Oral; Adult; AIDS Vaccines; Communicable Disease Control; Double-Blind Method; Female; HIV Infections; Humans; Male; Middle Aged; Organophosphonates; Placebos; Risk; Risk-Taking; Substance Abuse, Intravenous; Tenofovir; Thailand | 2011 |
13 other study(ies) available for organophosphonates and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Update to Interim Guidance for Preexposure Prophylaxis (PrEP) for the Prevention of HIV Infection: PrEP for injecting drug users.
Topics: Adenine; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Deoxycytidine; Emtricitabine; Female; Heterosexuality; HIV Infections; Homosexuality, Male; Humans; Male; Organophosphonates; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Substance Abuse, Intravenous; Tenofovir; United States | 2013 |
HIV pre-exposure prophylaxis in injecting drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous; Tenofovir | 2013 |
Preexposure prophylaxis reduces HIV risk in injection-drug users.
Topics: Adenine; Adult; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Comorbidity; Deoxycytidine; Drug Administration Schedule; Drug Users; Emtricitabine; Female; Follow-Up Studies; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Male; Organophosphonates; Practice Guidelines as Topic; Pregnancy; Risk Reduction Behavior; Substance Abuse, Intravenous; Tenofovir; United States | 2013 |
HIV antiretroviral prophylaxis for injecting drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
HIV antiretroviral prophylaxis for injecting drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
HIV antiretroviral prophylaxis for injecting drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
HIV antiretroviral prophylaxis for injecting drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
HIV antiretroviral prophylaxis for injecting drug users - Authors' reply.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
Prophylactic tenofovir reduced HIV infection in injectable drug users.
Topics: Adenine; Anti-HIV Agents; Female; HIV Infections; Humans; Male; Organophosphonates; Substance Abuse, Intravenous | 2013 |
[HIV infected women with intense bone and muscular pain and general weakness].
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Fanconi Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Muscle Weakness; Musculoskeletal Diseases; Organophosphonates; Osteomalacia; Pain; Radionuclide Imaging; Radiopharmaceuticals; Substance Abuse, Intravenous; Technetium Tc 99m Medronate; Tenofovir | 2011 |
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study.
Topics: Adenine; Adult; Analgesics, Opioid; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Maximum Tolerated Dose; Medication Adherence; Methadone; Middle Aged; Organophosphonates; Substance Abuse, Intravenous; Survival Rate; Tenofovir; Treatment Outcome; Viral Load; Young Adult | 2011 |
Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Brain; CD4 Lymphocyte Count; Cidofovir; Cytosine; Dideoxynucleosides; Encephalitis; False Negative Reactions; Fatal Outcome; Humans; Immunocompromised Host; Indinavir; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Organophosphonates; Substance Abuse, Intravenous; Time Factors; Virus Activation; Zidovudine | 2004 |
AIDS clinical trials. More woes for novel HIV prevention approach.
Topics: Adenine; Anti-HIV Agents; Centers for Disease Control and Prevention, U.S.; Clinical Trials as Topic; HIV Infections; Humans; Nigeria; Organophosphonates; Patient Selection; Sex Work; Substance Abuse, Intravenous; Tenofovir; Thailand; United States | 2005 |